Global Intravenous (IV) Solution Market Growth 2025-2031
Description
The global Intravenous (IV) Solution market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
LP Information, Inc. (LPI) ' newest research report, the “Intravenous (IV) Solution Industry Forecast” looks at past sales and reviews total world Intravenous (IV) Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous (IV) Solution sales for 2025 through 2031. With Intravenous (IV) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous (IV) Solution industry.
This Insight Report provides a comprehensive analysis of the global Intravenous (IV) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous (IV) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous (IV) Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous (IV) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous (IV) Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Total Parenteral Solution
Peripheral Parenteral Solution
Segmentation by Application:
Hospitals & Clinics
Ambulatory
Homecare
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intravenous (IV) Solution market?
What factors are driving Intravenous (IV) Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous (IV) Solution market opportunities vary by end market size?
How does Intravenous (IV) Solution break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 76%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
LP Information, Inc. (LPI) ' newest research report, the “Intravenous (IV) Solution Industry Forecast” looks at past sales and reviews total world Intravenous (IV) Solution sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous (IV) Solution sales for 2025 through 2031. With Intravenous (IV) Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous (IV) Solution industry.
This Insight Report provides a comprehensive analysis of the global Intravenous (IV) Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous (IV) Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intravenous (IV) Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous (IV) Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous (IV) Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous (IV) Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Total Parenteral Solution
Peripheral Parenteral Solution
Segmentation by Application:
Hospitals & Clinics
Ambulatory
Homecare
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical
Grifols
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intravenous (IV) Solution market?
What factors are driving Intravenous (IV) Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous (IV) Solution market opportunities vary by end market size?
How does Intravenous (IV) Solution break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
94 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Intravenous (IV) Solution by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Intravenous (IV) Solution by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
